AliveCor has raised $43.5M across 3 funding rounds, plus 2 undated rounds. The company is valued at $467.2M.
AliveCor received its first $3 million in financing in 2011, shortly after founder David Albert's prototype ECG device drew attention from venture capitalists and industry partners.
3 funding rounds, the latest highlighted.
AliveCor was founded in 2011, United States.
No date is disclosed for this round.
Qualcomm Incorporated (via Qualcomm Ventures and Qualcomm Life Fund), Oklahoma Life Sciences Fund. $10.5M raised, led by Burrill & Company, Khosla Ventures.
A primary round — the company sells new shares to investors it selects. Led by OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures, Bold Capital Partners.
No filing has been made.
3 dated rounds, newest first.
Mayo ClinicLEAD
GE HealthcareLEAD
Khosla VenturesLEADWWP Global PartnersLEADQQualcomm VenturesLEADBBold Capital PartnersLEADBBurrill & CompanyLEADOOMRENGGE HealthCare TechnologiesPPegasus Tech VenturesSSweetwater Private EquityHHuami CorpLead investors for each round are in the funding timeline.
The routes section explains what is realistically available for a company at this stage.
No. AliveCor is a private company; its shares do not trade on a public exchange.
The last valuation is $467.2M.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
